STUDY OF EFFECT OF GLYCEMIC CONTROL IN CKD DIABETIC PATIENTS AND THEIR RELATION TO HYPOGLYCEMIA C-PEPTIDE AND ISLET ANTIBODIES

Megalla, Magdy Helmi; Helmy, Mona Wagdy; Abd Elsalam, Mohamed Said; Koheya, Mohamed Said

doi:10.21608/alexpo.2024.265209.1780

STUDY OF EFFECT OF GLYCEMIC CONTROL IN CKD DIABETIC PATIENTS AND THEIR RELATION TO HYPOGLYCEMIA C-PEPTIDE AND ISLET ANTIBODIES

Document Type : Preliminary preprint short reports of original research

Authors

¹ Department of Internal Medicine, Faculty of Medicine, Alexandria University

² Department of Clinical and Chemical Pathology, Faculty of Medicine Alexandria University

³ Department of Internal Medicine , Faculty of Medicine , Alexandria University

10.21608/alexpo.2024.265209.1780

Abstract

Diabetes mellitus is a major public health issue with an increasing prevalence worldwide. In Egypt, DM is the leading cause of chronic kidney failure.
Classification: type I DM, type II DM, Gestational DM, MoDY, LADA.
Complication: Diabetic nephropathy is significant cause of morbidity and mortality in DM patients with progression to ESRD.

Figure (1): NICE/KDIGO classification of CKD using eGFR and ACR categories.

Hypoglycemic
Hypoglycemic is an essential and frequent adverse effect of glycemic control, as it causes significant morbidity and mortality. A plasma glucose concentration of

Keywords